Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Stakeholder participation in nuclear and radiological emergency preparedness and recovery in Spain: benefits and challenges of working together.

Liutsko L, Montero M, Trueba C, Sala R, Gallego E, Sarukhan A, Cardis E.

J Radiol Prot. 2019 Nov 8;40(1):N1-N8. doi: 10.1088/1361-6498/ab55cd. [Epub ahead of print]

PMID:
31703209
2.

Training through malaria research: building capacity in good clinical and laboratory practice in Liberia.

Mayor A, Martínez-Pérez G, Tarr-Attia CK, Breeze-Barry B, Sarukhan A, García-Sípido AM, Hurtado JC, Lansana DP, Casamitjana N.

Malar J. 2019 Apr 17;18(1):136. doi: 10.1186/s12936-019-2767-1.

3.

Community-informed research on malaria in pregnancy in Monrovia, Liberia: a grounded theory study.

Tarr-Attia CK, Bassat Q, Breeze-Barry B, Lansana DP, Meyer García-Sípido A, Sarukhan A, Maixenchs M, Mayor A, Martínez-Pérez G.

Malar J. 2018 Oct 23;17(1):382. doi: 10.1186/s12936-018-2529-5.

4.

Prevalence of Plasmodium falciparum infection among pregnant women at first antenatal visit in post-Ebola Monrovia, Liberia.

Martínez-Pérez G, Lansana DP, Omeonga S, Gupta H, Breeze-Barry B, González R, Bardají A, Sarukhan A, Goteh JDK, Tody E, Cisteró P, Benda B, Kercula JD, Kibungu FD, Meyer García-Sípido A, Bassat Q, Tarr-Attia CK, Mayor A.

Malar J. 2018 Oct 11;17(1):357. doi: 10.1186/s12936-018-2506-z.

5.

'Researchers have love for life': opportunities and barriers to engage pregnant women in malaria research in post-Ebola Liberia.

Martínez Pérez G, Tarr-Attia CK, Breeze-Barry B, Sarukhan A, Lansana DP, Meyer García-Sípido A, Rosés A, Maixenchs M, Bassat Q, Mayor A.

Malar J. 2018 Apr 2;17(1):132. doi: 10.1186/s12936-018-2292-7.

6.

Human CD6 Down-Modulation following T-Cell Activation Compromises Lymphocyte Survival and Proliferative Responses.

Carrasco E, Escoda-Ferran C, Climent N, Miró-Julià C, Simões IT, Martínez-Florensa M, Sarukhan A, Carreras E, Lozano F.

Front Immunol. 2017 Jun 30;8:769. doi: 10.3389/fimmu.2017.00769. eCollection 2017.

7.

CD6 modulates thymocyte selection and peripheral T cell homeostasis.

Orta-Mascaró M, Consuegra-Fernández M, Carreras E, Roncagalli R, Carreras-Sureda A, Alvarez P, Girard L, Simões I, Martínez-Florensa M, Aranda F, Merino R, Martínez VG, Vicente R, Merino J, Sarukhan A, Malissen M, Malissen B, Lozano F.

J Exp Med. 2016 Jul 25;213(8):1387-97. doi: 10.1084/jem.20151785. Epub 2016 Jul 4.

8.

Identification of a novel agrin-dependent pathway in cell signaling and adhesion within the erythroid niche.

Anselmo A, Lauranzano E, Soldani C, Ploia C, Angioni R, D'amico G, Sarukhan A, Mazzon C, Viola A.

Cell Death Differ. 2016 Aug;23(8):1322-30. doi: 10.1038/cdd.2016.10. Epub 2016 Mar 18.

9.

Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1.

Zanotti L, Angioni R, Calì B, Soldani C, Ploia C, Moalli F, Gargesha M, D'Amico G, Elliman S, Tedeschi G, Maffioli E, Negri A, Zacchigna S, Sarukhan A, Stein JV, Viola A.

Leukemia. 2016 May;30(5):1143-54. doi: 10.1038/leu.2016.33. Epub 2016 Feb 22.

10.

Mesenchymal stem cells: myths and reality.

Sarukhan A, Zanotti L, Viola A.

Swiss Med Wkly. 2015 Dec 23;145:w14229. doi: 10.4414/smw.2015.14229. eCollection 2015. Review.

11.

CD5 as a Target for Immune-Based Therapies.

Consuegra-Fernández M, Aranda F, Simões I, Orta M, Sarukhan A, Lozano F.

Crit Rev Immunol. 2015;35(2):85-115. Review.

PMID:
26351145
12.

Pattern Recognition by CD6: A Scavenger-Like Lymphocyte Receptor.

Sarukhan A, Martinez-Florensa M, Escoda-Ferran C, Carrasco E, Carreras E, Lozano F.

Curr Drug Targets. 2016;17(6):640-50. Review.

PMID:
25777272
13.

Adenosine triphosphate acts as a paracrine signaling molecule to reduce the motility of T cells.

Wang CM, Ploia C, Anselmi F, Sarukhan A, Viola A.

EMBO J. 2014 Jun 17;33(12):1354-64. doi: 10.15252/embj.201386666. Epub 2014 May 19.

14.

[The intestinal microbiota: a boost for antitumor treatments].

Sarukhan A.

Med Sci (Paris). 2014 Apr;30(4):436-8. doi: 10.1051/medsci/20143004019. Epub 2014 May 5. Review. French.

15.

Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues.

Van Overmeire E, Laoui D, Keirsse J, Van Ginderachter JA, Sarukhan A.

Front Immunol. 2014 Mar 26;5:127. doi: 10.3389/fimmu.2014.00127. eCollection 2014. Review.

16.

The CXCR4 mutations in WHIM syndrome impair the stability of the T-cell immunologic synapse.

Kallikourdis M, Trovato AE, Anselmi F, Sarukhan A, Roselli G, Tassone L, Badolato R, Viola A.

Blood. 2013 Aug 1;122(5):666-73. doi: 10.1182/blood-2012-10-461830. Epub 2013 Jun 21.

17.
18.

Encapsulated mesenchymal stem cells for in vivo immunomodulation.

Zanotti L, Sarukhan A, Dander E, Castor M, Cibella J, Soldani C, Trovato AE, Ploia C, Luca G, Calvitti M, Mancuso F, Arato I, Golemac M, Jonjic N, Biondi A, Calafiore R, Locati M, D'Amico G, Viola A.

Leukemia. 2013 Feb;27(2):500-3. doi: 10.1038/leu.2012.202. Epub 2012 Jul 18. No abstract available.

PMID:
22878604
19.

The pros and cons of chemokines in tumor immunology.

Viola A, Sarukhan A, Bronte V, Molon B.

Trends Immunol. 2012 Oct;33(10):496-504. doi: 10.1016/j.it.2012.05.007. Epub 2012 Jun 20. Review.

PMID:
22726608
20.

Agrin is required for survival and function of monocytic cells.

Mazzon C, Anselmo A, Soldani C, Cibella J, Ploia C, Moalli F, Burden SJ, Dustin ML, Sarukhan A, Viola A.

Blood. 2012 Jun 7;119(23):5502-11. doi: 10.1182/blood-2011-09-382812. Epub 2012 Apr 19.

21.

Control of murine Ly6C(high) monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6.

Savino B, Castor MG, Caronni N, Sarukhan A, Anselmo A, Buracchi C, Benvenuti F, Pinho V, Teixeira MM, Mantovani A, Locati M, Bonecchi R.

Blood. 2012 May 31;119(22):5250-60. doi: 10.1182/blood-2011-10-388082. Epub 2012 Apr 13. Erratum in: Blood. 2013 Mar 21;121(12):2371.

PMID:
22504926
22.

The critical role of agrin in the hematopoietic stem cell niche.

Mazzon C, Anselmo A, Cibella J, Soldani C, Destro A, Kim N, Roncalli M, Burden SJ, Dustin ML, Sarukhan A, Viola A.

Blood. 2011 Sep 8;118(10):2733-42. doi: 10.1182/blood-2011-01-331272. Epub 2011 Jun 7.

23.

Self-antigen presentation by mouse B cells results in regulatory T-cell induction rather than anergy or clonal deletion.

Morlacchi S, Soldani C, Viola A, Sarukhan A.

Blood. 2011 Jul 28;118(4):984-91. doi: 10.1182/blood-2011-02-336115. Epub 2011 Jun 7.

PMID:
21652680
24.

Regulatory T cells target chemokine secretion by dendritic cells independently of their capacity to regulate T cell proliferation.

Morlacchi S, Dal Secco V, Soldani C, Glaichenhaus N, Viola A, Sarukhan A.

J Immunol. 2011 Jun 15;186(12):6807-14. doi: 10.4049/jimmunol.1003265. Epub 2011 May 13.

25.

Tunable chemokine production by antigen presenting dendritic cells in response to changes in regulatory T cell frequency in mouse reactive lymph nodes.

Dal Secco V, Soldani C, Debrat C, Asperti-Boursin F, Donnadieu E, Viola A, Sarukhan A.

PLoS One. 2009 Nov 6;4(11):e7696. doi: 10.1371/journal.pone.0007696.

26.

A specific signalling signature characterizes the development of naturally occurring and antigen-specific regulatory T cells.

Nava K, Ordoñez-Rueda D, Sarukhán A, Chávez-Rios JR, García-Zepeda EA, Soldevila G.

Immunol Invest. 2009;38(8):851-67. doi: 10.3109/08820130903301055.

PMID:
19860593
27.

The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6.

Vetrano S, Borroni EM, Sarukhan A, Savino B, Bonecchi R, Correale C, Arena V, Fantini M, Roncalli M, Malesci A, Mantovani A, Locati M, Danese S.

Gut. 2010 Feb;59(2):197-206. doi: 10.1136/gut.2009.183772. Epub 2009 Oct 20.

PMID:
19846409
28.

Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling.

Ordoñez-Rueda D, Lozano F, Sarukhan A, Raman C, Garcia-Zepeda EA, Soldevila G.

Eur J Immunol. 2009 Aug;39(8):2233-47. doi: 10.1002/eji.200839053.

29.

Towards identification of the mechanisms of action of parasite-derived peptide GK1 on the immunogenicity of an influenza vaccine.

Segura-Velázquez R, Fragoso G, Sciutto E, Sarukhan A.

Clin Vaccine Immunol. 2009 Sep;16(9):1338-43. doi: 10.1128/CVI.00106-09. Epub 2009 Jul 15.

30.
31.

Immune regulation by self-reactive T cells is antigen specific.

Tanchot C, Vasseur F, Pontoux C, Garcia C, Sarukhan A.

J Immunol. 2004 Apr 1;172(7):4285-91.

32.

Tolerance induction to self antigens by peripheral dendritic cells.

Lambolez F, Jooss K, Vasseur F, Sarukhan A.

Eur J Immunol. 2002 Sep;32(9):2588-97.

33.

Origin of regulatory T cells with known specificity for antigen.

Apostolou I, Sarukhan A, Klein L, von Boehmer H.

Nat Immunol. 2002 Aug;3(8):756-63. Epub 2002 Jul 1.

PMID:
12089509
34.

Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera.

Casares S, Hurtado A, McEvoy RC, Sarukhan A, von Boehmer H, Brumeanu TD.

Nat Immunol. 2002 Apr;3(4):383-91. Epub 2002 Feb 25.

PMID:
11862219
35.

Regulatory function of in vivo anergized CD4(+) T cells.

Jooss K, Gjata B, Danos O, von Boehmer H, Sarukhan A.

Proc Natl Acad Sci U S A. 2001 Jul 17;98(15):8738-43. Epub 2001 Jul 3.

36.

Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors.

Sarukhan A, Soudais C, Danos O, Jooss K.

J Gene Med. 2001 May-Jun;3(3):260-70.

PMID:
11437331
37.

Fingerprints of anergic T cells.

Lechner O, Lauber J, Franzke A, Sarukhan A, von Boehmer H, Buer J.

Curr Biol. 2001 Apr 17;11(8):587-95.

38.

Successful interference with cellular immune responses to immunogenic proteins encoded by recombinant viral vectors.

Sarukhan A, Camugli S, Gjata B, von Boehmer H, Danos O, Jooss K.

J Virol. 2001 Jan;75(1):269-77.

39.

Monitoring gene expression of TNFR family members by beta-cells during development of autoimmune diabetes.

Walter U, Franzke A, Sarukhan A, Zober C, von Boehmer H, Buer J, Lechner O.

Eur J Immunol. 2000 Apr;30(4):1224-32. Erratum in: Eur J Immunol. 2003 Jul;33(7):2064. Frantzke A [corrected to Franzke A].

40.
41.

GAD, a single autoantigen for diabetes.

von Boehmer H, Sarukhan A.

Science. 1999 May 14;284(5417):1135, 1137. No abstract available.

PMID:
10366347
42.

Modifications of CD8+ T cell function during in vivo memory or tolerance induction.

Tanchot C, Guillaume S, Delon J, Bourgeois C, Franzke A, Sarukhan A, Trautmann A, Rocha B.

Immunity. 1998 May;8(5):581-90.

43.
44.

Involvement of the Fas (CD95) system in peripheral cell death and lymphoid organ development.

Laouar Y, Sarukhan A, Pasqualetto V, Garcia C, Ezine S.

Eur J Immunol. 1998 Mar;28(3):1078-88.

45.

Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model.

Sarukhan A, Lanoue A, Franzke A, Brousse N, Buer J, von Boehmer H.

EMBO J. 1998 Jan 2;17(1):71-80.

46.

Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo.

Buer J, Lanoue A, Franzke A, Garcia C, von Boehmer H, Sarukhan A.

J Exp Med. 1998 Jan 19;187(2):177-83.

47.

Conditions that induce tolerance in mature CD4+ T cells.

Lanoue A, Bona C, von Boehmer H, Sarukhan A.

J Exp Med. 1997 Feb 3;185(3):405-14.

49.

Anchored polymerase chain reaction based analysis of the V beta repertoire in the non-obese diabetic (NOD) mouse.

Sarukhan A, Gombert JM, Olivi M, Bach JF, Carnaud C, Garchon HJ.

Eur J Immunol. 1994 Aug;24(8):1750-6.

PMID:
7519993

Supplemental Content

Loading ...
Support Center